A prevailing strategy to manage non-paroxysmal atrial fibrillation (AF) that balances procedural risk and efficacy remains elusive. Despite technological advancements and refinements in our understanding of fibrillatory mechanisms,...
A prevailing strategy to manage non-paroxysmal atrial fibrillation (AF) that balances procedural risk and efficacy remains elusive. Despite technological advancements and refinements in our understanding of fibrillatory mechanisms,...
A prevailing strategy to manage...